Siemens, Medtronic jump through antitrust regulatory hoops
This article was originally published in Clinica
Executive Summary
US antitrust authorities has given the go-ahead to Siemens' proposed $7bn acquisition of Dade Behring, the German multinational's third and largest IVD transaction. Siemens began a tender offer for all issued and outstanding Dade stock, at $77 per share, on August 8 and has extended this offer until midnight September 26. The acquisition still requires EU antitrust approval - Siemens said it is in discussion with the European Commission and believes it can close the transaction during calendar 2007.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.